Patchwork Health co-founder launches clinician-led angel syndicate, Dx Capital 

Patchwork Health‘s workforce management solutions are used by over half of the NHS, optimising outcomes for organisations, managers, staff and patients alike. It was developed following the experiences of NHS Doctors Jing Ouyang and Anas Nader, who co-founded the company in 2016.

Now Non-Executive Director for the company, Jing is exploring how clinicians can work together to shape healthcare innovation through investment. In this Innovator Spotlight, Jing introduces Dx Capital (Differential Capital), which aims to strengthen access to capital, mentorship and healthcare expertise for early-stage health technology companies.

Interested in learning more about investment for healthtech innovation? Sign up to the HIN Investment Update.


Innovator spotlight: Dr Jing Ouyang, Co-Founder and Non-Executive Director, Patchwork Health

Dr Jing Ouyang, Non-Executive Director (NED) and Co-Founder of Patchwork and alumnus of the DigitalHealth.London Accelerator, has launched Dx Capital (Differential Capital) alongside Dr Meenakshi Jhala, a GP trainee and co-founder of Tiny Ventures, and Dr Azeem Alam BEM, a clinician entrepreneur, angel investor and founder of Deeplabel (by BiteLabs). This new clinician-led angel syndicate is designed to bridge the gap between traditional venture capital expectations and the realities of building healthcare companies.

Following nearly a decade building Patchwork, a leading NHS workforce solution, Jing has stepped back from day-to-day operations and now serves as a Non-Executive Director. Drawing on his experience raising capital from angel investors, venture capital firms, corporate investors and private equity, he is now focused on helping early-stage founders access the investment and expertise needed to scale.

Dx Capital emerged from conversations across the health innovation community. Through his podcast, Out of Programme; advisory work; and involvement in the wider ecosystem, Jing identified growing demand for a more coordinated approach to clinician-led investing. Jing explains: “One of the recurring topics that people kept bringing up was around the need for a clinician-based angel syndicate.”

Dx aims to help early-stage companies identify the funding strategies best suited to their business model and stage of growth. Alongside investment, the syndicate will provide access to practical healthcare expertise, mentorship and industry connections to support founders as they scale. The longer-term ambition is to develop the platform into a dedicated fund.

Initially operating through a deal-by-deal syndicate model, Dx Capital initially aims to aggregate smaller individual investments into larger health tech funding rounds over time. This will help to make angel investing more available for founders, whilst supporting access to engaged and experienced investors. One of the challenges that has been identified is that “many of the larger brand name VCs struggle to understand the total addressable market for a UK-based health tech,” Jing explains.

Following a successful launch event in the summer, where Dx Capital presented to a packed audience of clinicians, founders and investors, the fund was met with “so much inbound, so much interest [from the ecosystem],” shares Jing. After growing Patchwork from startup to a private equity-backed business, Jing sees Dx Capital as an opportunity to support founders following a similar journey.


Subscribe to the HIN Investment Update for key investment news, exclusive insights from the HIN’s investor network, and the latest opportunities and events. Ideal for growing healthtech companies, as well as funders and investors shaping the health innovation ecosystem.


Funded by UK Government. DigitalHealth.London. Health Innovation Network South London. NHS. Office for Life Sciences.